⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MXCT News
MaxCyte, Inc. Common Stock
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
globenewswire.com
MXCT
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
MXCT
Syntax Bio Announces Expanded Series A and Leadership Appointments
businesswire.com
MXCT
Form 8-K
sec.gov
MXCT
Form 8-K
sec.gov
MXCT
Form 8-K
sec.gov
MXCT
MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance
globenewswire.com
MXCT
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
globenewswire.com
MXCT
Form 8-K
sec.gov
BRNS
MXCT
SLDB
CLRB
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MXCT